Search

everythinglearnresearchcommunity

for

Search:↓

Promising cancer treatments were found, but the manufacturer closed.

A kidney transplant patient got a fungal infection from her dogs, but treatment improved her condition and hair grew back.

PLA2R1 overexpression harms kidney cells by stopping their growth cycle.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

PRP injections are safe for hair loss treatment, but monitoring and sun protection are advised.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

ILC1-like cells may contribute to hair loss in alopecia areata.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.